(CABA) - FDA

(CABA) – FDA

Mar 20, 2024 07:00 AM Cabaletta Bio (CABA) Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis
Feb 1, 2024 04:30 PM Cabaletta Bio (CABA) Granted FDA Orphan Drug Designation to CABA-201
Jan 8, 2024 07:02 AM
Nov 6, 2023 08:15 AM
Nov 6, 2023 07:00 AM
Oct 2, 2023 07:07 AM
May 16, 2023 07:01 AM
May 15, 2023 09:10 AM
May 15, 2023 09:08 AM
May 1, 2023 07:00 AM
Mar 31, 2023 07:00 AM
Oct 11, 2022 07:04 AM
Sep 12, 2022 05:21 AM
May 18, 2022 07:02 AM
Mar 1, 2022 08:02 AM
Dec 14, 2021 07:02 AM
Nov 1, 2021 07:07 AM
Oct 15, 2021 04:31 PM
Aug 18, 2021 07:10 AM
May 3, 2021 07:12 AM
Aug 25, 2020 08:06 AM
May 18, 2020 04:35 PM
May 6, 2020 08:07 AM
Jan 29, 2020 08:06 AM